---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-156113"
form_type: "8-K"
ticker: "SLNO"
cik: "0001484565"
company_name: "SOLENO THERAPEUTICS INC"
filed_at: "2024-06-06T23:59:59+00:00"
generated_at: "2026-06-01T05:52:35.231475+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Soleno shareholders elect director, ratify auditor, and approve expanded equity incentive plan

## Summary
- Andrew Sinclair elected as Class I director with 93.3% of votes cast (26.4M for, 1.9M withheld).
- Marcum LLP ratified as independent auditor for FY 2024 (29.2M for, 135K against).
- Amended 2014 Equity Incentive Plan approved (19.4M for, 8.9M against); share pool set at 5,825,762 shares plus annual 4% evergreen increase.
- Voter turnout of 87.7% (29,312,453 of 33,411,329 shares outstanding).

## SEC filing metadata
- accession: 0001193125-24-156113
- form_type: 8-K
- ticker: SLNO
- cik: 0001484565
- company_name: SOLENO THERAPEUTICS INC
- filed_at: 2024-06-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484565/000119312524156113/0001193125-24-156113-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484565/000119312524156113/d834951d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-156113
- JSON: https://secwatch.observer/filing/0001193125-24-156113.json
- Plain text: https://secwatch.observer/filing/0001193125-24-156113.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.